All In Biotech

Free tool

FAERS Monitor: Dovato

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 211994 or its brand name (Dovato, Dolutegravir Sodium, Lamivudine). Reports on generic versions are filed under their own applications.

Reports

3,600

Serious

1,372

38% of reports

Hospitalization

435

Death reported

120

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • product dose omission issue1,096
  • inappropriate schedule of product administration256
  • product dose omission in error224
  • product use issue195
  • anxiety155
  • pain142
  • drug ineffective137
  • rash126
  • fatigue122
  • viral load increased121
  • pathogen resistance119
  • off label use110
  • intentional dose omission109
  • emotional distress102
  • incorrect dose administered98

Reports by year received

View as table
YearReports
20152
20162
20174
20185
201990
2020214
2021306
2022546
2023865
2024761
2025577
2026228

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,050,559 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
viral load increasedSignal121187.9157.321,620
pathogen resistanceSignal11977.364.78,771
product dose omission in errorSignal22446.641.09,879
intentional dose omissionSignal10922.418.62,204
product dose omission issueSignal1,09621.920.822,015
inappropriate schedule of product administrationSignal2568.37.41,651
product use issueSignal1956.15.3827
emotional distressSignal1024.94.1317
anxietySignal1553.22.7233
incorrect dose administeredSignal982.52.188
rash1261.71.435
pain1421.41.113
fatigue1220.90.81
off label use1100.70.611
drug ineffective1370.60.537

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.